Viewing Study NCT00280059


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-05-13 @ 3:19 PM
Study NCT ID: NCT00280059
Status: COMPLETED
Last Update Posted: 2021-01-28
First Post: 2006-01-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy, Partial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epilepsy View
None partial seizures View
None pregabalin monotherapy View
None lamotrigine comparator View
None double-blind and randomized trial View